2m 2m 2m 2m 2m 2m 2m
ACTUATE THERAP (ACTU)
NASDAQ
$1.08+$0.009 (+0.84%)
Price as of Sep 11, 2026 7:30 PM EDT- $25.7MMarket Cap
- -83.96%1-Year Change
- BiotechnologyIndustry
ACTUATE THERAP (ACTU)
$1.08+$0.009 (+0.84%)
ACTU | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.07 | ||
Change | -$0.08 (-6.96%) | ||
Open | $1.15 | ||
High | $1.23 | ||
Low | $1.03 | ||
Previous Close | $1.15 | ||
Volume | 239,600 | ||
30-Day Average Volume | 465,145 | ||
1-Week Change | -27.70% | ||
1-Month Change | 5.94% | ||
1-Year Change | -83.96% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 24.0M | ||
Total Assets | $5.2M | ||
Market Cap | $25.7M | ||
Enterprise Value | $21.3M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$4.4M | ||
EBIT | $0.00 | ||
EBITDA | $0.00 | ||
Net Working Capital | $942,745.00 | ||
EPS | -$0.20 | ||
Enterprise Value/EBITDA | N/A | ||
Enterprise Value/Revenue | N/A | ||
P/B | 26 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue